# Maximus, Inc.: Form 10-Q for the period ended Jun 30, 2013

- Company: [Maximus, Inc.](/companies/mms.md) (CIK 1032220)
- Form: 10-Q
- Filed: 2013-08-09
- Accepted by EDGAR: Aug 9, 2013, 20:08 ET
- Period: 2013-06-30
- Accession: 0001104659-13-062331
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1032220/000110465913062331/a13-13010_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1032220/000110465913062331/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-04-01 to 2013-06-30 | $334.3m | us-gaap:Revenues |
| Revenue | 9 months, 2012-10-01 to 2013-06-30 | $946.9m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2013-04-01 to 2013-06-30 | $239.8m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months, 2012-10-01 to 2013-06-30 | $678.4m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2013-04-01 to 2013-06-30 | $94.6m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2012-10-01 to 2013-06-30 | $268.5m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2013-04-01 to 2013-06-30 | $49.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2012-10-01 to 2013-06-30 | $138.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-04-01 to 2013-06-30 | $44.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2012-10-01 to 2013-06-30 | $129.1m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2013-04-01 to 2013-06-30 | $28.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2012-10-01 to 2013-06-30 | $81.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-04-01 to 2013-06-30 | $0.40 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2012-10-01 to 2013-06-30 | $1.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-04-01 to 2013-06-30 | $0.41 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2012-10-01 to 2013-06-30 | $1.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-04-01 to 2013-06-30 | 69,867,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2012-10-01 to 2013-06-30 | 69,864,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2012-10-01 to 2013-06-30 | $88.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2012-10-01 to 2013-06-30 | $24.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2012-10-01 to 2013-06-30 | $9.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2012-10-01 to 2013-06-30 | $27.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2013-06-30 | $187.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-06-30 | $502.9m | us-gaap:AssetsCurrent |
| Total assets | at 2013-06-30 | $759.1m | us-gaap:Assets |
| Current liabilities | at 2013-06-30 | $226.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-06-30 | $268.1m | us-gaap:Liabilities |
| Long-term debt | at 2013-06-30 | $1.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2013-06-30 | $167.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2013-06-30 | $491.0m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 32,711 characters.

*The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of, and should be read in conjunction with, our Consolidated Financial Statements and related Notes included both herein and in our Annual Report on Form 10-K for the year ended September 30, 2012, filed with the Securities and Exchange Commission on November 16, 2012.*

### Business Overview

We provide business process outsourcing services to government health and human services agencies under our mission of *Helping Government Serve the People.®* Our business is focused almost exclusively on administering government-sponsored programs. Founded in 1975, we are one of the largest pure-play health and human services administrative providers to governments in the United States, Australia, Canada, the United Kingdom and Saudi Arabia. We use our expertise, experience and advanced technological solutions to help government agencies run efficient, cost-effective programs and to improve program accountability, while enhancing the quality of services provided to program beneficiaries.

The Company is managed through two segments, Health Services and Human Services. The Health Services Segment provides a variety of business process outsourcing and administrative support services, as well as consulting services for state, provincial and federal programs, such as Medicaid, CHIP, Medicare, and the British Columbia Health Insurance Program. The Human Services Segment includes a variety of business process outsourcing, case management, job training, and support services for programs such as welfare-to-work programs, child support enforcement, K-12 special education, and other specialized consulting services.

Within the United States, the Company’s core competencies place it in a strong position to assist governments with many of the facets of the Affordable Care Act (ACA), as well as other health and human services initiatives. Many states are proceeding with the provision of health insurances exchanges and addressing other requirements mandated by law. MAXIMUS is already benefitting from new work related to the ACA and expects this will continue to grow as states transition from the Federal exchange to the state-based exchanges, expand Medicaid and seek assistance to meet the various requirements of the ACA. These changes, coupled with other federal mandates and local initiatives, place a significant burden on state governments at a time of increasing demand for critical services from the most vulnerable members of society. Many states have taken steps to control costs and increase the effectiveness of their social programs, such as Medicaid by shifting more populations to managed care, increasing co-pays, reducing provider rates, and modifying benefits. As more populations shift into Medicaid managed care, demand for our administrative services and program volumes generally increases. Further, several states are expanding or contemplating expanding Medicaid over the next several years

International governments have unique local issues to address in addition to general global economic factors. Our international contracts are typically driven by welfare reforms designed to better manage resources and our compensation under these contracts is frequently tied to our ability to move people off public benefits and into long-term employment. Companies like MAXIMUS may benefit from the need for governments to reform certain benefits programs.

On July 1, 2013, the Company acquired Health Management Limited (HML), a business based in the United Kingdom. No results from this business have been included in the results discussed below. On April 30, 2012, the Company acquired Policy Studies, Inc. (PSI), the results of which have been included in the Company’s results after this time.

### Trends and uncertainties

The implementation of the ACA in the United States has provided opportunities for MAXIMUS within our Health Services segment, notably in the provision of services related to the federal and state-based health insurance exchanges and Medicaid expansion across the United States. MAXIMUS estimates that it has added more than $150 million in new annual contract value for next year related to new health insurance contracts. The implementation of new contracts may require investment in both fixed assets and working capital. In many cases, all or part of our capital investment is reimbursed by the customer at the start of the contract.

The Company’s principal customers are governments, many of which are currently constrained by reduced budgets. We have experienced isolated instances of government agencies putting additional administrative processes in place prior to paying their vendor obligations, resulting in some increases in receivables and days sales outstanding. We believe this is isolated and these funds will be collected within the current fiscal year.

### Results of Operations

#### Consolidated

The following table sets forth, for the periods indicated, selected statements of operations data:

*(amounts in thousands, except per share data)*

|  | Three Months Ended June 30, 2013 | 2012 | Nine Months Ended June 30, 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $334,323 | $266,353 | $946,940 | $749,408 |
| Gross profit | $94,560 | $78,701 | $268,534 | $203,314 |
| Gross profit margin | 28.3% | 29.5% | 28.4% | 27.1% |
| Selling, general and administrative expenses | $49,181 | $43,877 | $138,096 | $114,592 |
| Selling, general and administrative expense as a percentage of revenue | 14.7% | 16.5% | 14.6% | 15.3% |
| Acquisition-related expenses | 1,174 | 1,877 | 1,500 | 2,110 |
| Legal and settlement expenses/(recoveries), net | (182) | (352) | (202) | (990) |
| Operating income from continuing operations | $44,387 | $33,299 | $129,140 | $87,602 |
| Operating margin from continuing operations percentage | 13.3% | 12.5% | 13.6% | 11.7% |
| Interest and other income, net | 701 | 1,164 | 2,444 | 3,092 |
| Income from continuing operations before income taxes | 45,088 | 34,463 | 131,584 | 90,694 |
| Provision for income taxes | 17,052 | 13,987 | 50,051 | 38,349 |
| Tax rate | 37.8% | 40.6% | 38.0% | 42.3% |
| Income from continuing operations, net of income taxes | $28,036 | $20,476 | $81,533 | $52,345 |
| Income (loss) from discontinued operations, net of income taxes | $64 | $9 | $(428) | $117 |
| Net income | $28,100 | $20,485 | $81,105 | $52,462 |
| **Basic earnings (loss) per share:** |  |  |  |  |
| Income from continuing operations | $0.41 | $0.30 | $1.20 | $0.77 |
| Income (loss) from discontinued operations | — | — | (0.01) | 0.01 |
| Basic earnings per share | $0.41 | $0.30 | $1.19 | $0.78 |
| **Diluted earnings (loss) per share:** |  |  |  |  |
| Income from continuing operations | $0.40 | $0.29 | $1.17 | $0.75 |
| Income (loss) from discontinued operations | — | — | (0.01) | 0.01 |
| Diluted earnings per share | $0.40 | $0.29 | $1.16 | $0.76 |

All common stock share and per share amounts have been adjusted for the two-for-one stock split in June 2013.

The following provides an overview of the significant elements of our Consolidated Statements of Operations. As each of our business segments have different factors driving revenue growth and profitability, the sections that follow cover these segments in greater detail.

The Company uses certain measurements which are considered “non-GAAP”, namely organic revenue growth and revenue, operating income, operating margin and earnings per share excluding the effect of a contract termination discussed below. We believe that the presentation of these “non-GAAP numbers” assists the user of these financial statements in understanding the results of our business and assessing the performance of the Company. However, these non-GAAP numbers should not be used in isolation or used as alternatives to revenue growth, revenue, operating income, operating margin and earnings per share.

The results for the nine month period ended June 30, 2013 was affected by a one-time benefit from the termination of a system-integration contract acquired with PSI. This termination resulted in one-time, non-cash benefits to revenue of $16.0 million and gross and operating profit of $10.9 million. Although contract terminations for convenience do occur within our business, they are infrequent. In addition, this termination is unusual due to the significant effect of the transaction, which is highly unlikely to be repeated, as it involves deferred revenue from the PSI acquisition and does not reflect the underlying business operations of the Company. Accordingly, we discuss below the results of the business both including and excluding the effect of this contract termination. We believe the presentation of revenue, operating income, operating margins and earnings per share excluding the effect of this contract termination provide a useful basis for assessing the Company’s performance compared to prior periods or our competitors. However, these numbers are “non-GAAP” numbers and are not meant to be considered in isolation or as alternatives to their GAAP equivalents as measures of performance.

We discuss organic growth revenue to provide a framework for assessing how our business performed excluding the effects of the acquisition of PSI. Organic revenue growth comparisons are performed by excluding all PSI revenues from all periods discussed.

Revenue for the three month period ended June 30, 2013 increased 25.5% to $334.3 million, compared to the comparative period in the prior year. Excluding PSI’s business, the Company recorded organic growth of 25.9%. Revenue for the nine months ended June 30, 2013 increased 26.4% to $946.9 million, compared to the comparative period in the prior year, with organic growth being 15.4% for the same period. Both segments experienced organic growth. The principal drivers of the changes in the segments are discussed in more detail below.

Sales pipeline at June 30, 2013 was $2.2 billion, compared to $3.4 billion at June 30, 2012. The decrease is largely due to sales opportunities being converted into new awards. At the start of the current year, the Company had a significant number of new contracts in start-up and these converted opportunities were the principal driver behind the current fiscal year’s growth in revenue. The sales pipeline only reflects opportunities where the request for proposal (RFP) is expected to be released within the next six months. Under most circumstances, contract opportunities that are carried within the pipeline reflect the base contract value and do not include future option periods. Option periods are typically reported in the pipeline six months before they are eligible to be exercised. For contracts with the United States Federal Government, it is common to see a single year base contract with multiple options, whereas state, local and international contracts typically have longer base periods. Our assessment of pipeline reflects only opportunities that the Company is pursuing or planning to pursue and should not be considered as indicative of guaranteed future revenues.

Gross profit increased by 20.2% to $94.6 million for the three month period ended June 30, 2013 and increased 32.1% to $268.5 million for the nine month period ended June 30, 2013, compared to the comparative periods in fiscal year 2012. The growth in both cases was driven by a combination of organic growth and the acquisition of PSI. Fluctuations in gross margins within each segment are discussed below.

Selling, general and administrative expense (SG&A) consists of costs related to general management, marketing and administration. These costs include salaries, benefits, bid and proposal efforts, travel, recruiting, continuing education, employee training, non-chargeable labor costs, facilities costs, printing, reproduction, communications, equipment depreciation, intangible amortization and legal expenses incurred in the ordinary course of business. The improvement in SG&A as a percentage of revenue has been driven by the integration of PSI and the growth of the business in the United Kingdom. The acquisition of PSI occurred in the comparative period, which included redundant SG&A costs which were eliminated in future periods. The business in the United Kingdom has relatively fixed SG&A but has recorded revenue growth in fiscal year 2013 as the contract receives the benefit of being fully ramped up.

Acquisition-related expenses relate to the costs incurred directly as a consequence of the acquisitions of HML and PSI as well as costs directly related to acquisitions which were not concluded in the period. The Company incurred $0.9 million of expenses directly relating to the acquisition of HML during the three month period ended June 30, 2013. These costs were principally legal and due diligence charges. All charges in fiscal year 2012 relate to the acquisition of PSI. Charges include legal and due diligence costs, as well as severance directly related to the acquisition.

Legal and settlement expense (recovery), net consists of costs, net of reimbursed insurance claims, related to significant legal settlements and non-routine legal matters, including future probable legal costs estimated to be incurred in connection with those matters. Legal expenses incurred in the ordinary course of business are included in selling, general and administrative expense. The following table sets forth the matters that represent legal and settlement expense (recovery), net:

*(in thousands)*

|  | Three months Ended June 30, 2013 | 2012 | Nine Months Ended June 30, 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Insurance Recoveries | (390) | (445) | (390) | (1,181) |
| Other | 208 | 93 | 188 | 191 |
| Total | $(182) | $(352) | $(202) | $(990) |

Operating income from continuing operations increased 33% to $44.4 million for the three months ended June 30, 2013 compared to the same period in the prior year. Operating income from continuing operations increased 47% to $129.1 million for the nine months ended June 30, 2013 compared to the comparative period in the prior year. Excluding the effect of the contract termination noted above, growth for the nine month period ended would have been 35%. These increases were driven by organic growth and the acquisition of PSI.

Interest and other income, net includes interest earned on cash and cash equivalents and on a note received by the Company for the disposal of a business in fiscal year 2008. The balance also includes immaterial foreign exchange gains and losses and the noncontrolling interest of our operations in Saudi Arabia. Almost all of the income recorded represents income from interest on cash accounts in overseas jurisdictions and this income is expected to decline owing to the use of funds for the HML acquisition.

The provision for income taxes in the three and nine months ended June 30, 2013 was $17.1 million and $50.1 million, respectively, reflecting effective tax rates of 37.8% and 38.0%, respectively. The comparative tax rates in fiscal year 2012 were higher owing to the correction of an immaterial error of $1.6 million related to prior years.

Income from continuing operations, net of income taxes, was $28.0 million, or $0.40 per diluted share, for the three months ended June 30, 2013, compared with $20.5 million, or $0.29 per diluted share, for the same period in fiscal year 2012. For the nine month periods ended June 30, 2013 and 2012, income from continuing operations, net of income taxes was $81.5 million and $52.3 million, or $1.17 and $0.75 per diluted share, respectively. For the nine month period ending June 30, 2013, net income and diluted earnings per share included the one-time benefits of $6.5 million and $0.09, respectively, from the contract termination noted above.

#### Health Services

*(amounts in thousands)*

|  | Three Months Ended June 30, 2013 | 2012 | Nine Months Ended June 30, 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $217,901 | $170,403 | $591,847 | $489,616 |
| Gross profit | 62,868 | 50,787 | 162,778 | 127,923 |
| Operating income | 34,361 | 25,652 | 83,896 | 60,637 |
| Gross profit margin | 28.9% | 29.8% | 27.5% | 26.1% |
| Operating margin percentage | 15.8% | 15.1% | 14.2% | 12.4% |

Revenue increased by 27.9% and 20.9% for the three and nine month periods ended June 30, 2013, compared with the comparative periods in fiscal year 2012. Organic growth, excluding the revenues of PSI, was 27.1% and 15.3% for the three and nine months ended June 30, 2013, respectively. This growth includes new work, including that associated with state health insurance exchanges, and strong volumes in our Federal Medicare appeals business.

Our gross profit and operating income increased as a consequence of this accretive revenue growth. However, results in fiscal year 2012 received the benefit of $10.2 million from a contract amendment which also affected gross profit and operating profit. Without this, gross profit margin in both comparative periods would have been approximately 25% and operating margin approximately 10%.

We continue to see strong demand in our health business and have recently won health exchange contract work in Hawaii, Maryland and the District of Columbia. We cannot accurately predict the volume of Federal Medicare appeals we will be asked to provide but we currently anticipate this business to remain stable in future periods at the level recorded in the most recent fiscal quarter.

#### Human Services

*(amounts in thousands)*

|  | Three Months Ended June 30, 2013 | 2012 | Nine Months Ended June 30, 2013 | 2012 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $116,422 | $95,950 | $355,093 | $259,792 |
| Gross profit | 31,692 | 27,914 | 105,756 | 75,391 |
| Operating income | 11,018 | 9,187 | 46,159 | 28,100 |
| Gross profit margin | 27.2% | 29.1% | 29.8% | 29.0% |
| Operating margin percentage | 9.5% | 9.6% | 13.0% | 10.8% |

Revenue increased by 21.3% and 36.7% for the three and nine month periods ended June 30, 2013, compared with the comparative periods in fiscal year 2012. Organic growth for the same periods is 23.6% and 15.6%, respectively. Included within the revenue for the nine months ended June 30, 2013 is $16.0 million relating to the terminated contract noted above. Excluding this unusual item, revenue increased by 30.5%. Organic revenue growth was driven by the Company’s international operations, notably in the United Kingdom.

Gross profit margin and operating profit margin for the three month period ended June 30, 2013 both declined compared to the prior year period. Both gross and operating profit in fiscal year 2012 received the benefit of $4.4 million related to a change order on a fixed-price contract, which was beneficial to margins. The declines also reflect lower margins in Australia, where changes in the contract have required additional resources, offset by margin improvements in the United Kingdom, related to the ongoing ramp up, and in Saudi Arabia, which began in the fourth quarter of fiscal year 2012.

Gross profit margin and operating margin for the nine months ended June 30, 2013 improved when compared to prior years. However, this improvement was principally driven by the $10.9 million favorable effect of the terminated contract, without which margins would be comparable to prior years. A calculation of adjusted gross and operating profit margins is shown below.

*(amounts in thousands)*

|  | Nine Months Ended June 30, 2013 |
| --- | ---: |
| Revenue | $355,093 |
| Less revenue from terminated contract | (16,035) |
| Revenue excluding terminated contract | $339,058 |
| Gross profit | $105,756 |
| Less gross profit from terminated contract | (10,900) |
| Gross profit excluding terminated contract | $94,856 |
| Operating income | $46,159 |
| Less operating income from terminated contract | (10,900) |
| Operating income excluding terminated contract | $35,259 |
| Gross profit margin percentage excluding terminated contract | 28.0% |
| Operating margin percentage excluding terminated contract | 10.4% |

The nine month period ended June 30, 2012 received the benefit of $6.8 million related to change orders on a fixed-price contract. The nine month period ended June 30, 2013 was adversely affected by lower margins in Australia, offset by growth in the United Kingdom and Saudi Arabia. The lower margins in Australia were driven by required changes from the government, principally in increased documentation and regulatory oversight. Margins for this business are currently anticipated to remain at levels consistent with the three month period ended June 30, 2013.

#### Discontinued operations

During fiscal year 2013, the Company incurred a pre-tax expense of $1.0 million related to arbitration proceedings pertaining to a discontinued operation.

During fiscal years 2012 and 2013, the Company recorded gains on sale from the disposal of a business in 2008. The terms of the sale included a promissory note. At June 30, 2013, the promissory note had a value of $3.2 million and is fully reserved. No further payments are certain at this time. The Company recorded pre-tax gains of $0.1 million in the three month periods ended June 30, 2013 and 2012 and recorded pre-tax gains of $0.3 million for the nine month periods ended June 30, 2013 and 2012.

### Liquidity and Capital Resources

In March 2013, the Company entered into an unsecured, five-year revolving credit agreement (the “Credit Agreement”) with SunTrust Robinson Humphrey as arranger and book manager with Bank of America N.A. and HSBC USA N.A. as co-syndication agents. The Credit Agreement provides for a revolving line of credit up to $100 million and is available for general corporate purposes including working capital expenses, capital expenditures and certain permitted acquisitions. The Credit Agreement charges borrowings at a base rate, a Eurodollar rate or an index rate plus an applicable percentage based upon the Company’s total leverage ratio. The Company is required to comply with certain financial covenants, including a maximum leverage ratio and a minimum fixed charge ratio, as well as customary restrictions on liens, sales of assets, restrictive agreements, affiliate transactions and other matters. In the event that the Company’s total leverage ratio equals or exceeds 2.5:1.0, the Credit Agreement also includes restrictions or limits on the Company’s ability to incur or guarantee additional indebtedness, make loans or investments, declare dividends or buy back common stock. At June 30, 2013, the Company was in compliance with all covenants. At June 30, 2013, the Company’s only indebtedness under the Credit Agreement relates to letters of credit of $15.5 million. Accordingly, the Company has access to up to $84.5 million of funds from the Credit Agreement. The Company’s only other indebtedness comprises two letters of credit totaling $3.0 million and a $1.5 million interest-free loan from the Atlantic Innovation Fund of Canada, the proceeds of which must be used for specific purposes.

At June 30, 2013, the Company held $187.9 million in cash and cash equivalents. Included in this total was $71.4 million of cash used to acquire HML on July 1, 2013. The funds used to acquire HML were held in overseas locations and, after this transaction, the Company continues to hold approximately 60% of its cash and cash equivalents in overseas locations. If we were to transfer these funds to the United States, the Company would be required to accrue and pay additional taxes. We do not intend to repatriate these funds and, accordingly, we have not attempted to quantify the charges which might arise if we were to make this transaction. The charges would vary based upon tax legislation in the United States and the other overseas jurisdictions as well as the manner and timing in which MAXIMUS would make these transactions.

In general, although some overseas locations have required initial investment, the Company has been able to utilize cash flows from operations to fund working capital and capital expenditure requirements in all locations in which it has operated and the Company continues to expect that this will be the case. In addition, domestic cash flows have been sufficient to cover operating requirements as well as dividends, share repurchases and acquisitions. The principal source of these cash inflows are payments from customers, the timing of which may be driven by billing schedules and payment terms. Where contracts are performance-based, a project may experience cash outflows for several quarters before cash inflows are received. In addition, the Company has faced short-term delays in payments from certain customers, typically domestic customers, all of which were ultimately recovered. The Company believes that the combination of strong cash flows, large cash balances and access to the new credit facility should be sufficient to maintain liquidity in the event of protracted delays in payments although extended payment delays would adversely affect cash flows and the Company’s costs.

#### Cash Flows

*(amounts in thousands)*

| Net cash provided by (used in): | Nine Months Ended June 30, 2013 | 2012 |
| --- | ---: | ---: |
| Operating activities — continuing operations | $89,162 | $85,061 |
| Operating activities — discontinued operations | (587) | — |
| Investing activities — continuing operations | (34,856) | (78,195) |
| Financing activities — continuing operations | (39,494) | (13,565) |
| Effect of exchange rate changes on cash and cash equivalents | (15,626) | 2,649 |
| Decrease in cash and cash equivalents | $(1,401) | $(4,050) |

Cash provided by operating activities from continuing operations for the nine months ended June 30, 2013 was $89.2 million, compared with $85.1 million in the same period in fiscal year 2012. The increase of $4.1 million is significantly less than the increase in net income of $28.6 million, reflecting a combination of increased working capital from the growth of the business as well as payment delays from two large contracts in the United States. The delays relate to administrative delays on the part of the clients. However, we anticipate that these matters will be resolved shortly and that our operating cash receipts will receive a benefit during our fourth fiscal quarter.

Cash flows from discontinued operations relate to arbitration expenses incurred in addressing legal matters for a discontinued line of business.

Cash used in investing activities from continuing operations for the nine months ended June 30, 2013 was $34.9 million, compared to $78.2 million for the same period in fiscal year 2012. The prior period includes $66.0 million used to acquire PSI, offset in the current period by a receipt of $3.4 million related to the final settlement of the purchase price. The balance is principally driven by capital investment in the significant number of projects started during the current fiscal year. Future investing cash flows will be contingent upon new business awards.

Cash used in financing activities from continuing operations for the nine months ended June 30, 2013 was $39.5 million, compared to $13.6 million for the same period in fiscal year 2012. The principal driver of this growth was an increase of $17.9 million for share repurchases of common stock, an increase of $4.4 million related to employee tax withholding on restricted stock units and a reduction of $4.6 million of funds received from employee stock transactions. In the nine months of fiscal year 2013, 251,000 stock options were exercised, compared with 800,000 stock options in the first nine months of fiscal year 2012.

The Company’s cash balance decreased by $15.6 million in the nine-month period ended June 30, 2013 owing to foreign exchange rate fluctuations. The principal driver of this change was the weakening of the Australian Dollar against the United States Dollar.

To supplement our statements of cash flows presented on a GAAP basis, we use the non-GAAP measure of free cash flows from continuing operations to analyze the funds generated from operations. We believe free cash flow from continuing operations is a useful basis for comparing our performance with our competitors. The presentation of non-GAAP free cash flows from continuing operations is not meant to be considered in isolation, or as an alternative to net income as an indicator of performance, or as an alternative to cash flows from operating activities as a measure of liquidity. We calculate free cash flow from continuing operations as follows:

*(amounts in thousands)*

|  | Nine Months Ended June 30, 2013 | 2012 |
| --- | ---: | ---: |
| Cash provided by operating activities — continuing operations | $89,162 | $85,061 |
| Purchases of property and equipment | (24,869) | (11,884) |
| Capitalized software costs | (13,652) | (2,850) |
| Free cash flow from continuing operations | $50,641 | $70,327 |

#### Repurchases of the Company’s common stock

Under a resolution adopted in November 2011, the Board of Directors has authorized the repurchase, at management’s discretion, of up to an aggregate of $125.0 million of the Company’s common stock. The resolution also authorizes the use of option exercise proceeds for the repurchase of the Company’s common stock. During the nine months ended June 30, 2013, the Company repurchased 828,898 common shares at a cost of $27.0 million. At June 30, 2013, $102.2 million is available for future stock repurchases. Under an earlier repurchase plan, the Company repurchased 480,400 common shares at a cost of $8.9 million, during the nine month period ended June 30, 2012.

#### Letters of Credit and Performance Bonds

Certain contracts require us to provide a letter of credit or a surety bond as a guarantee of performance. At June 30, 2013, the Company had letters of credit totaling $15.5 million and performance bond commitments totaling $50.9 million. These letters of credit and performance bonds are typically renewed annually and remain in place until the contractual obligations have been satisfied. Although the triggering events vary from contract to contract, in general, we would only be liable for the amount of these guarantees in the event of default in our performance of our obligations under each contract, the probability of which we believe is remote.

#### Dividend

On July 5, 2013, the Company’s Board of Directors declared a quarterly cash dividend of $0.045 for each share of the Company’s common stock outstanding. The dividend is payable on August 30, 2013, to shareholders of record on August 15, 2013.

### Critical Accounting Policies and Estimates

Our discussion and analysis of financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenue and expenses. On an ongoing basis, we evaluate our estimates including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill, and amounts related to income taxes, certain accrued liabilities and contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.

We believe that we do not have material off-balance-sheet risk or exposure to liabilities that are not recorded or disclosed in our financial statements. While we have significant operating lease commitments for office space, those commitments are generally tied to the period of performance under related contracts. Additionally, although on certain contracts we are bound by performance bond commitments and standby letters of credit, we have not had any defaults resulting in draws on performance bonds. Also, we do not speculate in derivative transactions.

During the three months ended June 30, 2013, there were no significant changes to the critical accounting policies we disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the year ended September 30, 2012.

## Market risk

As filed, 407 characters.

We believe that our exposure to market risk related to the effect of changes in interest rates, foreign currency exchange rates, commodity prices and other market risks with regard to instruments entered into for trading or for other purposes is immaterial.

There have been no material changes in the information presented in Item 7A of our Annual Report on Form 10-K for the year ended September 30, 2012.

## Controls and procedures

As filed, 1,546 characters.

(a) Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 396 characters.

In connection with information set forth in this Form 10-Q, the factors discussed under “Risk Factors” in our Form 10-K for fiscal year ended September 30, 2012 should be considered. The risks included in the Form 10-K could materially and adversely affect our business, financial condition and results of operations. There have been no material changes to the factors discussed in our Form 10-K.

Filed Aug 9, 2013.
Source: SEC EDGAR, the filing index for accession 0001104659-13-062331. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
